Vaccination with plasmid DNA against infectious pathogens including dengue is an active area of investigation. By design, DNA vaccines are able to elicit both antibody responses and cellular immune responses capable of mediating long-term protection. Great technical improvements have been made in dengue DNA vaccine constructs and trials are underway to study these in the clinic. The scope of this review is to highlight the rich history of this vaccine platform and the work in dengue DNA vaccines accomplished by scientists at the Naval Medical Research Center. This work resulted in the only dengue DNA vaccine tested in a clinical trial to date. Additional advancements paving the road ahead in dengue DNA vaccine development are also discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2011.07.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Rapid On-Site Detection Method for Plasmodium falciparum Carried by Mosquitoes Using Disc Microfluidic Isothermal Amplification.
Am J Trop Med Hyg
December 2024
Department of Pathogenic Biology, Basic Medical College, Naval Medical University, Shanghai, China.
Rapidly identifying Anopheles-carrying malaria parasites is crucial for imported malaria prevention. However, suitable methods still lack quick detection in limited-resource situations. In this study, disc microfluidic isothermal amplification integrating loop-mediated isothermal amplification (LAMP) and microfluidic chip technology were applied to develop rapid and precise detection with low resource requirements.
View Article and Find Full Text PDFAssociation of IL10 gene polymorphism with the susceptibility to dengue and disease severity in a population with asymptomatic and symptomatic dengue.
Acta Trop
December 2024
Laboratório de Biologia de Microrganismos, Programa de Pós-Graduacão em Ciências Biomédicas, Universidade Federal do Delta do Parnaíba, Campus Ministro Reis Velloso Avenida São Sebastião, 2819; Bairro Reis Velloso, Parnaíba, Piauí, Brazil. Electronic address:
Article Synopsis
- Infections from the dengue virus, Orthoflavivirus denguei, can show no symptoms or a range of clinical signs due to its complex interactions with viral and host factors.
- The study examined specific genetic variations (SNPs) in the interleukin-10 (IL-10) gene among 333 individuals in northeastern Brazil to see how they relate to symptomatic dengue.
- Findings revealed that certain genotypes and the G allele of the -1082 A/G SNP are associated with a higher risk of developing symptomatic dengue, particularly in contrast to those with asymptomatic infections.
Development of a controlled-release mosquito RNAi yeast larvicide suitable for the sustained control of large water storage containers.
Sci Rep
December 2024
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Raclin-Carmichael Hall, 1234 Notre Dame Ave., South Bend, IN, 46617, USA.
Article Synopsis
- Large household water storage containers are key breeding sites for Aedes aegypti mosquitoes, which spread diseases like dengue.
- Concerns over insecticide resistance and safety are challenging effective mosquito control, leading researchers to explore RNAi-based yeast larvicides as a solution.
- A study developed a shelf-stable, controlled-release yeast formulation that shows promise for lasting mosquito control, demonstrating effectiveness in various container sizes and remaining active for up to six months.
Sindbis Virus Replicon-Based SARS-CoV-2 and Dengue Combined Vaccine Candidates Elicit Immune Responses and Provide Protective Immunity in Mice.
Vaccines (Basel)
November 2024
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
: Since its emergence in 2019, the rapid spread of SARS-CoV-2 led to the global pandemic. Recent large-scale dengue fever outbreaks overlapped with the COVID-19 pandemic, leading to increased cases of co-infection and posing severe public health risks. Accordingly, the development of effective combined SARS-CoV-2 and dengue virus (DENV) vaccines is necessary to control the spread and prevalence of both viruses.
View Article and Find Full Text PDFCRISPR-Cas Systems Associated with Electrolyte-Gated Graphene-Based Transistors: How They Work and How to Combine Them.
Biosensors (Basel)
November 2024
ITODYS, CNRS, Université Paris Cité, F-75006 Paris, France.
Article Synopsis
- The review discusses advances in combining CRISPR-Cas systems with graphene-based electrolyte-gated transistors for improved sensing technology.
- It explains how CRISPR-Cas systems can amplify molecular signals, while transistor devices can enhance electrical signals, potentially surpassing traditional PCR methods in sensitivity.
- The text highlights the urgency for rapid and cost-effective viral RNA detection, particularly due to the COVID-19 pandemic, and mentions the interest in detecting other RNA viruses like dengue and Ebola.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!